Measles-mumps-rubella vaccine at 6 months of age, immunology, and childhood morbidity in a high-income setting.

Trial Profile

Measles-mumps-rubella vaccine at 6 months of age, immunology, and childhood morbidity in a high-income setting.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Feb 2017

At a glance

  • Drugs Measles mumps and rubella virus vaccine (Primary) ; Measles mumps and rubella virus vaccine (Primary)
  • Indications Measles; Mumps; Rubella
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms The 6 months MMR Trial
  • Most Recent Events

    • 17 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top